Protek Pharmaceuticals
| MCX: PRTK | |
| Founded | 1990 |
| Headquarters | , Russia |
| Revenue | $4.43 billion[1] (2017) |
| $138 million[1] (2017) | |
| $101 million[1] (2017) | |
| Total assets | $2.32 billion[1] (2017) |
| Total equity | $579 million[1] (2017) |
Number of employees | 15,300 |
Protek (Russian: Протек) is a Russian company that includes drug manufacturing, retail, and distribution. It is one of the largest pharmaceutical companies of Russia.[2] It was founded in 1990 by Vadim Yakunin and Grigor Khachaturov.[3] In 2022, the company's revenue in Russia amounted to 257 billion rubles.[4]
See also
[edit]References
[edit]
- ^ a b c d e http://www.protek-group.ru/upload/iblock/761/PAO-PROTEK_MSFO_KFO_2017.pdf.
{{cite web}}: Missing or empty|title=(help) - ^ "Russia - Country Commercial Guide - Pharmaceuticals". International Trade Administration (which operates trade.gov). 2020-11-14. Retrieved June 17, 2021.
- ^ "Russian drug firm Protek in talks with new partner". Reuters. Archived from the original on 2022-12-18.
- ^ "АО ЦВ Протек". www.rusprofile.ru (in Russian). Retrieved 2023-11-30.
 | This Russian corporation or company article is a stub. You can help Wikipedia by expanding it. |